. . . . . . . "[?2-AR antagonism selectively suppresses the growth of CRC accompanying active ?2-AR signaling, which potentially carries wild-type KRAS, in vitro and in vivo via the inhibition of ?2-AR transactivated EFGR-Akt/ERK1/2 signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:10:18+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .